Why are T cells tolerant to hepatitis B virus?

Oct 14, 2008

The level of PD-1 expression has been proved by recent studies to be positively correlated with the extent of HBV-specific T cell impairments. However, the degree of T cell exhaustion which affects the disease statuses of hepatitis B patients has so far been only evaluated in restricted and small groups of patients between those with established chronicity and subjects with acute HBV infection. Besides, whether levels of PD-1 expression on T cells differ between acute exacerbation of hepatitis B and chronic HBV infected patients is still unknown.

A research article to be published on July 28, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Shu-Ling Zhang from Tongji Medical College of Huazhong University of Science and Technology in China examined the expression of PD-1 on antigen specific CD8+ T cells in peripheral blood of chronic hepatitis B (CHB) and acute exacerbation of hepatitis B (AEHB) patients.

They found that the levels of PD-1 on total CD8+ T cells in CHB patients were significantly higher than those in AEHB patients and healthy individuals. Conversely, lower frequencies of HBV-specific CD8+ T cells were detected in samples from chronic patients compared to AEHB patients. Our results confirmed reports that HBV specific CD8+ T-cell responses in peripheral blood were intensified in samples from AEHB patients than in those from patients with chronic hepatitis who remains viral persistence.

Besides, there was a significant positive correlation between HBV viral load and percentage of PD-1 expression on CD8+ T cells in CHB and AEHB group of subjects. However, PD-1 expression was not in association with disease flare-ups indicator alanine aminotransferase (ALT). This study clarified the correlation between PD-1 expression and two different HBV infection statuses.

Source: World Journal of Gastroenterology

Explore further: Mystery of the reverse-wired eyeball solved

add to favorites email to friend print save as pdf

Related Stories

Bristol-Myers pitches its cancer medicine pipeline

Jun 06, 2011

(AP) -- Bristol-Myers Squibb Co. executives said Monday they have more than a half-dozen drugs in testing against different cancers and could get important data on them and possibly a couple of approvals this year.

Recommended for you

Mystery of the reverse-wired eyeball solved

23 hours ago

From a practical standpoint, the wiring of the human eye - a product of our evolutionary baggage - doesn't make a lot of sense. In vertebrates, photoreceptors are located behind the neurons in the back of the eye - resulting ...

Neurons controlling appetite made from skin cells

23 hours ago

Researchers have for the first time successfully converted adult human skin cells into neurons of the type that regulate appetite, providing a patient-specific model for studying the neurophysiology of weight ...

Quality control for adult stem cell treatment

Feb 27, 2015

A team of European researchers has devised a strategy to ensure that adult epidermal stem cells are safe before they are used as treatments for patients. The approach involves a clonal strategy where stem cells are collected ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.